首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

北美生物生產市場預測至 2030 年 - 區域分析 - 按產品、應用、設備和最終用戶

市場調查報告書

商品編碼

1510610

北美生物生產市場預測至 2030 年 - 區域分析 - 按產品、應用、設備和最終用戶

North America Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 95 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美生物生產市場價值為109.4748億美元，預計2030年將達到313.7365億美元；預計2022年至2030年複合年成長率為14.1%。

再生藥物的不斷採用推動了北美生物生產市場

再生療法有助於細胞、組織和器官的再生，以恢復其功能。每年都會向美國食品藥物管理局（FDA）提交一些人體臨床試驗的再生醫學申請。根據再生醫學聯盟的數據，2019年第三季度，全球正在進行1,052項利用再生醫學的臨床試驗； 2019 年正在進行 218 項細胞療法試驗（41 項 I 期試驗、147 項 II 期試驗、30 項 III 期試驗）。細胞療法是再生醫學領域成長最快的領域之一。諾華的 Kymriah 是第一個用於治療 B 細胞急性白血病的細胞治療解決方案。此外，再生醫學提供者RepliCel擁有多種再生醫學產品正在研發中，其中RCH-01、RCS-01和RCT-01這三個產品正處於開發階段。此外，Sernova 致力於再生醫學技術的開發，並擁有針對糖尿病、A 型血友病和甲狀腺功能亢進等疾病的龐大產品線。因此，再生藥物的日益普及正在推動生物生產市場的發展。

北美生物生產市場概況

北美生物生產市場細分為美國、加拿大和墨西哥。在墨西哥，由於幹細胞治療的醫療旅遊業不斷成長，對細胞治療的需求非常引人注目。由於糖尿病和不孕症發病率的增加以及生物相似藥產品開發的不斷增加，北美的生物生產市場在 2022 年佔據了最大的市場佔有率。

遺傳和細胞疾病發病率的不斷上升導致對細胞療法的需求不斷增加。 2020 年 PhRMA 關於細胞和基因治療管道的報告顯示，美國有 400 種細胞和基因療法正在開發中，以針對從癌症到遺傳性疾病到神經系統疾病等多種疾病和病症。截至2020年2月，有九種細胞或基因治療產品在美國獲得批准，用於治療癌症、眼部疾病和罕見遺傳疾病。此外，越來越多的新創公司正在該國創新細胞療法。

北美生物生產市場收入及 2030 年預測（百萬美元）

北美生物生產市場細分

北美生物生產市場分為產品、應用、設備、最終用戶和國家。

根據產品，北美生物生產市場分為生物製劑和生物相似藥、疫苗、細胞和基因療法、核酸療法等。 2022 年，生物製劑和生物相似藥領域佔據北美最大的生物生產市場。

在應用方面，北美生物生產市場分為類風濕性關節炎、血液疾病、癌症、糖尿病、心血管疾病等。到 2022 年，癌症領域將佔據北美最大的生物生產市場。

依設備分類，北美生物生產市場分為上游設備、下游設備、生物反應器、耗材及配件。 2022 年，消耗品和配件領域佔據北美最大的生物生產市場。

就最終用戶而言，北美生物生產市場分為生物製藥公司、合約製造組織等。 2022 年，生物製藥公司細分市場佔據北美最大的生物生產市場。

按國家/地區分類，北美生物生產市場分為美國、加拿大和墨西哥。 2022年，美國在北美生物生產市場佔有率中佔據主導地位。

Bio-Rad Laboratories Inc、丹納赫公司、F. Hoffmann-La Roche Ltd、Lonza Group AG、Merck KGaA、Sartorius AG 和 Thermo Fisher Scientific Inc. 是北美生物生產市場上的一些領先公司。

Regenerative therapies help in the regeneration of cells, tissues, and organs to restore their functions. A number of regenerative medicine applications for human clinical trials are submitted to the Food and Drug Administration (FDA) each year. As per the Alliance for Regenerative Medicine, in 2019 (Q3), 1,052 clinical trials utilizing regenerative medicine were underway globally; 218 cellular therapy trials were underway (41 Phase I, 147 Phase II, 30 Phase III) in 2019. Rapid advancements are being made in regenerative medicines to provide effective solutions for chronic conditions. Cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis' Kymriah was the first cell therapy solution offered to treat B-cell acute leukemia. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in the pipeline, with three products-RCH-01, RCS-01, and RCT-01-in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of products for conditions such as diabetes, hemophilia A, and hyperthyroidism. Thus, the rising adoption of regenerative medicines is driving the bioproduction market.

North America Bioproduction Market Overview

The North America bioproduction market is subsegmented into the US, Canada, and Mexico. In Mexico, the demand for cell therapy is quite noteworthy owing to growing medical tourism for stem cell therapy. The bioproduction market in North America accounted for the largest market share in 2022 due to increasing incidence of diabetes and infertility, as well as rising product developments in biosimilars.

Growing incidences of genetic and cellular disorders are leading to increasing demand for cell therapies. A 2020 PhRMA report on the cell and gene therapy pipeline revealed that there are 400 cell and gene therapies in development to target a variety of diseases and conditions from cancer to genetic disorders to neurologic conditions in the US. As of February 2020, nine cell or gene therapy products were approved in the US to treat cancer, eye diseases and rare hereditary diseases. Also, an increasing number of start-ups are innovating cell therapies in the country.

North America Bioproduction Market Revenue and Forecast to 2030 (US$ Million)

North America Bioproduction Market Segmentation

The North America bioproduction market is categorized into product, application, equipment, end user, and country.

Based on product, the North America bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest North America bioproduction market share in 2022.

In terms of application, the North America bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest North America bioproduction market share in 2022.

By equipment, the North America bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest North America bioproduction market share in 2022.

In terms of end user, the North America bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest North America bioproduction market share in 2022.

By country, the North America bioproduction market is segmented into the US, Canada, and Mexico. The US dominated the North America bioproduction market share in 2022.

Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the North America bioproduction market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Adoption of Regenerative Medicines
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
- 4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
- 4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis

5. Bioproduction Market - North America Market Analysis

5.1 North America Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. North America Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
- 6.3.1 Overview
- 6.3.2 Biologics and Biosimilars: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
- 6.4.1 Overview
- 6.4.2 Vaccines: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
- 6.5.1 Overview
- 6.5.2 Cell and Gene Therapies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
- 6.6.1 Overview
- 6.6.2 Nucleic Acid Therapeutics: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
- 7.3.1 Overview
- 7.3.2 Cancer: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
- 7.4.1 Overview
- 7.4.2 Cardiovascular Diseases: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
- 7.5.1 Overview
- 7.5.2 Rheumatoid Arthritis: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Disorders: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
- 7.7.1 Overview
- 7.7.2 Diabetes: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview
8.2 North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
- 8.3.1 Overview
- 8.3.2 Consumables and Accessories: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
- 8.4.1 Overview
- 8.4.2 Downstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
- 8.5.1 Overview
- 8.5.2 Bioreactors: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.5.2.1 North America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
- 8.6.1 Overview
- 8.6.2 Upstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Biopharmaceutical Companies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
- 9.4.1 Overview
- 9.4.2 Contract Manufacturing Organizations: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 North America: Bioproduction Market
- 10.1.1 US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.1 Overview
  - 10.1.1.2 US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.3 US: Bioproduction Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.4 US: Bioproduction Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.5 US: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.1 US: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
  - 10.1.1.6 US: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Canada: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Canada: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.5 Canada: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.5.1 Canada: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.6 Canada: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Mexico: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.3.4 Mexico: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.5 Mexico: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.5.1 Mexico: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.6 Mexico: Bioproduction Market, by End User, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Danaher Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sartorius AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Merck KGaA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Bioproduction Market Segmentation
Table 2. North America Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. US Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. US Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market

List Of Figures

Figure 1. North America Bioproduction Market Segmentation, By Country
Figure 2. North America Bioproduction Market: Key Industry Dynamics
Figure 3. North America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. North America: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market